A small study conducted at the University of Minnesota [ 20 ] showed a trend toward an improved outcome in patients treated with imatinib during the pre- and posttransplantation periods.
← all excerpts
Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China.
1
—
—